Register for the UK NEQAS for Molecular Genetics EQA schemes and discover what our service can offer your laboratory.


EQA schemes

Learn more about the schemes which UK NEQAS for Molecular Genetics provide to help improve the quality of your laboratory’s service.



Refer to our online participants' manual for guidance on participating in our schemes.


News & Events

Guidance for NGS of solid tumours

UK NEQAS for Molecular Genetics has also been involved in the recent publication of consensus opinion on Next Generation Sequencing of solid tumours. Deans et al Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL Virchows Archiv DOI 10.1007/s00428-016-2025-7.

Colorectal cancer publication

We are pleased to inform you that UK NEQAS for Molecular Genetics has published data on the extended RAS testing performed by participating laboratories - How close are we to standardised extended RAS testing? The UK NEQAS evaluation. Susan D Richman, Jennifer Fairley, Rachel Butler, Zandra C Deans. JCP Online First, published on September 28, 2016 as 10.1136/jclinpath-2016-203822

User survey 2016

Thank you for your continued participation in the UK NEQAS for Molecular Genetics EQA schemes. In order for us to continue to provide EQA schemes to meet your needs we would like to invite you to complete an online survey which can be accessed at The will close on Friday 23rd September, 2016 23:59h GMT.
We very much appreciate your time in helping us to review and develop the EQA scheme.

Welcome to UK NEQAS for Molecular Genetics

The United Kingdom National External Quality Assessment Services (UK NEQAS) for Molecular Genetics provides external quality assessment for a range of inherited diseases  and acquired disorders currently tested in diagnostic molecular laboratories. 

UK NEQAS for Molecular Genetics gives objective information and advice to clinical laboratories throughout laboratory molecular medicine on the quality of their analytical and interpretative performance, in order to help them provide accurate and reliable test results and advice to clinicians, which facilitates optimal patient care. Advances in our understanding of genetic diseases has led to a revolution in testing technologies. UK NEQAS for Molecular Genetics is committed to providing external quality assessment in this rapidly evolving field.

The Scheme was granted unconditional accreditation by Clinical Pathology Accreditation in January 2001 until March 2016. The Scheme has been granted UK Accreditation Service (UKAS) accredititaion to ISO 17043 in March, 2016 and the scope can be accessed at


In addition to external quality assessment (EQA) for Molecular Genetics and Molecular Pathology, the Edinburgh centre also provides EQA for Peptide hormones, Tumour markers, Pregnancy testing and Maternal serum screening see

NHS Lothian operating UK NEQAS for Molecular Genetics.  UK NEQAS for Molecular Genetics is a member of the United Kingdom National External Quality Assessment Service (UK NEQAS), which is a Company Limited by Guarantee (No. 3012351) and a Registered UK Charity (No. 1044013). For more information on the UK NEQAS organisation see

Subscribe to UKNEQAS for Molecular Genetics RSS